---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000081"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:44:58.394989+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q1 2024 revenue $197.9M; adjusted EBITDA $62.8M

## Summary
- Revenue (GAAP and adjusted) of $197.9M; net loss $1.0M; adjusted net income $32.6M.
- Adjusted EBITDA $62.8M (31.7% margin); operating cash flow $42.6M.
- Exited Q1 with ~8 million consumers of prescription-related offerings.
- Interim CEO Scott Wagner cites progress and path to return to 'Rule of 40' company.

## SEC filing metadata
- accession: 0001809519-24-000081
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000081/0001809519-24-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000081/gdrx-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000081
- JSON: https://secwatch.observer/filing/0001809519-24-000081.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000081.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported the three months ended March 31, 2024 results: revenue $197.9 million, net income Net loss of $1.0 million.
  - Period: the three months ended March 31, 2024
  - Revenue: $197.9 million
  - Net income: Net loss of $1.0 million
  - Result: reported results
  source text: for prescription savings in the U.S., has released its financial results for the first quarter of 2024. First Quarter 2024 Highlights • Revenue 1 and Adjusted Revenue 1 of $197.9 million • Net loss of $1.0 million; Net loss margin of 0.5% • Adjusted Net Income 1 of $32.6 million; Adjusted Net Income Margin 1 of 16.5% • Adjusted EBITDA 1 of $62.8 million; Adjusted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000081/0001809519-24-000081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.